Anti-Ro52 Autoantibody Is Common in Systemic Autoimmune Rheumatic Diseases and Correlating with Worse Outcome when Associated with interstitial lung disease in Systemic Sclerosis and Autoimmune Myositis

Abstract This review highlights the 30 plus years research progress since the discovery of autoantibody to Ro52/TRIM21 in patients with systemic lupus erythematosus (SLE) and Sjögren’s syndrome (SjS). After the initial expression cloning of the Ro52 cDNA, it has taken many years to the current understanding in the interesting biological function of Ro52 as an E3 ubiquitin ligase and its role in innate immune clearance of intracellular IgG-bound complex. Early observations show that anti-Ro52, mostly associated with anti-SS-A/Ro60 and/or anti-SS-B/La, is commonly found in SLE (40–70%), SjS (70–90%), neonatal lupus erythematosus (NLE, 75–90%), and subacute cutaneous lupus erythematosus (50–60%). Anti-Ro52 has long been postulated to play a direct pathogenic role in congenital heart block in NLE as well as in the QT interval prolongation in some adults. The widespread availability of the anti-Ro52 assay has led to the detection of anti-Ro52 in other diseases including autoimmune hepatitis (20–40%), systemic sclerosis (10–30%), and autoimmune myositis (20–40%). More than ten studies have pointed to an association of anti-Ro52 with interstitial lung disease and, more importantly, correlating with poor outcome and worse survival. Other studies are implicating an interesting role for anti-Ro52 in the diagnosis of certain cancers. Future studies are needed to examine the mechanism in the pathogenesis of anti-Ro52 and carefully documenting its causal relationships in different disease conditions..

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:63

Enthalten in:

Clinical reviews in allergy & immunology - 63(2022), 2 vom: 18. Jan., Seite 178-193

Sprache:

Englisch

Beteiligte Personen:

Chan, Edward K. L. [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

Autoantibody
Autoimmune hepatitis
Autoimmune myositis
Interstitial lung disease
Ro52
Sjögren’s syndrome
Systemic lupus erythematosus
Systemic sclerosis

Anmerkungen:

© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021

doi:

10.1007/s12016-021-08911-z

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2131984499

Zugang & Verfügbarkeit




Zugehörige Publikationen/Bände

    Haven't found what you're looking for?